It was announced today that Pfizer will be acquiring Vicuron Pharmaceuticals, a company that focuses on novel anti-infectives for both hospital-based and community-acquired infections.
Pfizer Buying Vicuron For Nearly $2 Billion
Pfizer is acquiring Vicuron Pharmaceuticals, a company that is dedicated to novel anti-infectives for both hospital-based and community-acquired infections.